![]() |
|
|
JS Dayton, LA Turka, CB Thompson and BS Mitchell
Department of Pharmacology, University of Michigan, Ann Arbor.
The immunosuppressive drug mizoribine has been demonstrated to inhibit T lymphocyte proliferation by depleting these cells of guanine ribonucleotides as a consequence of inhibiting the enzyme inosine monophosphate (IMP) dehydrogenase. Because the immunosuppressive agents azathioprine and 6-mercaptopurine (6MP) are both converted to the IMP analog 6-thio-IMP, we postulated that these drugs might inhibit T cell activation and/or proliferation by a similar mechanism. Incubation of isolated peripheral blood T cells with either mizoribine or the selective IMP dehydrogenase inhibitor mycophenolic acid caused a dose- dependent inhibition of T cell proliferation, which was reversible with the addition of 50 microM guanosine to replete guanine ribonucleotide pools. In contrast, guanosine exacerbated the inhibition of proliferation induced by azathioprine and restored proliferation at IC50 concentrations of 6MP by only 10%. Complete restoration of proliferation in the presence of 6MP, but not azathioprine, was achieved with the addition of adenine. The inhibitory effects of azathioprine, as well as those of mizoribine, 6MP, and mycophenolic acid, were identical in cells stimulated with antibody to the T cell receptor and in cells stimulated with phorbol ester and ionomycin. We conclude from these studies that mizoribine selectively inhibits guanine ribonucleotide formation in purified T cells, whereas the effect of 6MP appears to be more dependent on adenine ribonucleotide depletion. Azathioprine, on the other hand, inhibits proliferation by a mechanism independent of purine ribonucleotide depletion. None of these agents inhibits T cell proliferation by interfering with signal transduction mediated by the T cell receptor. Inhibition of guanine ribonucleotide biosynthesis appears to be a novel and perhaps more selective mechanism of inhibiting T cell proliferative responses after T cell activation.
This article has been cited by other articles:
![]() |
H. Long, S. Cameron, L. Yu, and Y. Rao De Novo GMP Synthesis Is Required for Axon Guidance in Drosophila Genetics, March 1, 2006; 172(3): 1633 - 1642. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Ku, M. McCartan, and D. Collier Clinical Pharmacokinetic and Pharmacodynamic Monitoring for Mycophenolate Mofetil Journal of Pharmacy Practice, December 1, 2005; 18(6): 422 - 431. [Abstract] [PDF] |
||||
![]() |
A C Allison Mechanisms of action of mycophenolate mofetil Lupus, March 1, 2005; 14(3_suppl): s2 - s8. [Abstract] [PDF] |
||||
![]() |
C. W. Thomas, G. M. Myhre, R. Tschumper, R. Sreekumar, D. Jelinek, D. J. McKean, J. J. Lipsky, W. J. Sandborn, and L. J. Egan Selective Inhibition of Inflammatory Gene Expression in Activated T Lymphocytes: A Mechanism of Immune Suppression by Thiopurines J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 537 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Allison Mechanisms of action of mycophenolate mofetil Lupus, January 1, 2005; 14(1_suppl): s2 - s8. [Abstract] [PDF] |
||||
![]() |
M. A. Kamal and W. J. Jusko Interactions of Prednisolone and Other Immunosuppressants Used in Dual Treatment of Systemic Lupus Erythematosus in Lymphocyte Proliferation Assays J. Clin. Pharmacol., September 1, 2004; 44(9): 1034 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Sievers New Antiproliferative Immunosuppressive Agents Journal of Pharmacy Practice, December 1, 2003; 16(6): 401 - 413. [Abstract] [PDF] |
||||
![]() |
J. J. Gu, A. K. Tolin, J. Jain, H. Huang, L. Santiago, and B. S. Mitchell Targeted Disruption of the Inosine 5'-Monophosphate Dehydrogenase Type I Gene in Mice Mol. Cell. Biol., September 15, 2003; 23(18): 6702 - 6712. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Quemeneur, L.-M. Gerland, M. Flacher, M. Ffrench, J.-P. Revillard, and L. Genestier Differential Control of Cell Cycle, Proliferation, and Survival of Primary T Lymphocytes by Purine and Pyrimidine Nucleotides J. Immunol., May 15, 2003; 170(10): 4986 - 4995. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Quemeneur, M. Flacher, L.-M. Gerland, M. Ffrench, J.-P. Revillard, and N. Bonnefoy-Berard Mycophenolic Acid Inhibits IL-2-Dependent T Cell Proliferation, But Not IL-2-Dependent Survival and Sensitization to Apoptosis J. Immunol., September 1, 2002; 169(5): 2747 - 2755. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Korn, K. Toyka, H.-P. Hartung, and S. Jung Suppression of experimental autoimmune neuritis by leflunomide Brain, September 1, 2001; 124(9): 1791 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Korecka, D. Nikolic, R. B. van Breemen, and L. M. Shaw The Apparent Inhibition of Inosine Monophosphate Dehydrogenase by Mycophenolic Acid Glucuronide Is Attributable to the Presence of Trace Quantities of Mycophenolic Acid Clin. Chem., July 1, 1999; 45(7): 1047 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Laliberte, A. Yee, Y. Xiong, and B. S. Mitchell Effects of Guanine Nucleotide Depletion on Cell Cycle Progression in Human T Lymphocytes Blood, April 15, 1998; 91(8): 2896 - 2904. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Zimmermann, K. L. Wright, J. P.-Y. Ting, and B. S. Mitchell Regulation of Inosine-5'-monophosphate Dehydrogenase Type II Gene Expression in Human T Cells. ROLE FOR A NOVEL 5' PALINDROMIC OCTAMER SEQUENCE J. Biol. Chem., September 5, 1997; 272(36): 22913 - 22923. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hortelano and L. Bosca 6-Mercaptopurine Decreases the Bcl-2/Bax Ratio and Induces Apoptosis in Activated Splenic B Lymphocytes Mol. Pharmacol., March 1, 1997; 51(3): 414 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Gu, J. Spychala, and B. S. Mitchell Regulation of the Human Inosine Monophosphate Dehydrogenase Type I Gene. UTILIZATION OF ALTERNATIVE PROMOTERS J. Biol. Chem., February 14, 1997; 272(7): 4458 - 4466. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Fairbanks, M. Bofill, K. Ruckemann, and H. A. Simmonds Importance of Ribonucleotide Availability to Proliferating T-lymphocytes from Healthy Humans J. Biol. Chem., December 15, 1995; 270(50): 29682 - 29689. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Zimmermann, J. Spychala, and B. S. Mitchell Characterization of the Human Inosine-5`-monophosphate Dehydrogenase Type II Gene J. Biol. Chem., March 24, 1995; 270(12): 6808 - 6814. [Abstract] [Full Text] [PDF] |
||||